EDITORIAL BOARD MEMBERS
Research Department of Physiological Sciences Center for Veterinary Health Sciences
Oklahoma State University
USA
BIOGRAPHY:
Dr. Teluguakula Narasaraju is an Assistant Professor, Research Department of Physiological Sciences Center for Veterinary Health Sciences Oklahoma State University, Stillwater, Oklhoma USA. He has been working in the field of “respiratory and infectious diseases” for more than 18 years. H developed interest on respiratory diseases right from his early research career, especially on influenza viruses. He obtained postdoctoral training in lung biology laboratory at Oklahoma State University, USA. His work resulted in 12 peer-reviewed publications in 3 years. During this period he developed hyperoxia model, which mimic bronchopulmonary dysplasia in humans, most common chronic respiratory disease that affects preterm infants due to mechanical ventilation, oxygen toxicity and infection. He has shown that insulin-like growth factor-1 helps in alveolar repair by promoting alveolar epithelial differentiation, critical for lung regeneration after injury. He continued his research at National University of Singapore, Singapore on influenza viruses after briefly working on SARS corona virus ion identifying cytotoxic T-cell epitopes for DNA vaccine. For the past 8 years, his research is mainly focused on the role of innate immune cells in influenza virus pathogenesis. Broad research interest in my laboratory is to explore the role of innate immune response in influenza virus pathogenesis. His studies have shown that excessive neutrophils and their released neutrophil extracellular traps (NETs) exacerbate lung damage, which ultimately progress into acute respiratory distress syndrome (ARDS). Most recently, his team have identified that histone proteins present in NETs play key role in tissue injury by promoting microvascular thrombosis and cytotoxicity through toll-like receptor signaling. Investigating the mechanisms of histone-mediated lung injury & ARDS and testing anti-histone antibodies in a “combination therapy” together with antiviral agents, is one of the major focuses of research in his laboratory.
RESEARCH INTERESTS:
Dr. Teluguakula Narasaraju's research interests includes Influenza, respiratory viruses and lung biology.
OTHER EDITORIAL BOARD MEMBER
Department of Medicine and Infectious Diseases
Mount Sinai School of Medicine
United States
Department of Pathology, Microbiology and Immunology
School of Medicine
University of South Carolina
United States
Department of Pathology and laboratory Medicine
University of Calgary
Canada
Department of Pathology and Laboratory Medicine
Temple University Hospital
United States
Department of Microbiology & Immunology
Penn State University
United States
Department of Microbiology
King Saud Bin Abdulaziz University for Health Sciences
Saudi Arabia
Department of Global Environmental Health Sciences
Tulane University
United States
STI/HIV/Hepatitis/TB Programs
Arkansas Department of Health
USA
Department of Medical and Surgical Sciences
University of Bologna
Italy
School of Medical & Applied Sciences
Central Queensland University
Australia
Department of Microbial, Biochemical and Food Biotechnology
University of the Free State
South Africa
School of Public Health
The University of Hong Kong
Hong Kong
Department of Biological Science
Sungkyunkwan University
Korea
Department of Virology
The Stephan Angeloff Institute of Microbiology
Bulgaria
Department of Clinical Pathology
Mansoura University
Egypt
Department of Microbiology
College of Medicine
University of Tikrit
Iraq
Pharmacognosy and Api-Phytotherapy Research Laboratory Mostaganem
University of Algiers
Algeria
